Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Short term Debt (2009 - 2021)

Updated

Tg Therapeutics' Short term Debt came in at $975,000 for Q4 2021, down 95.6% from $22.18 million a year earlier and down 93.9% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Short term Debt (2009 - 2021) Analysis & Trends

Going back to Q2 2020, Tg Therapeutics' Short term Debt data covers 7 quarters.

  • Going back by year, Short term Debt was $22.18 million in FY2020.
  • Business Quant data shows TGTX's Short term Debt at $16 million (Q3 2021), $23.16 million (Q2 2021) and $30.13 million (Q1 2021) in the three quarters before Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 975,000.00
Sep 30, 2021 16.00 Mn
Jun 30, 2021 23.16 Mn
Mar 31, 2021 30.13 Mn
Dec 31, 2020 22.18 Mn
Sep 30, 2020 14.59 Mn
Jun 30, 2020 7.20 Mn
Dec 31, 2010 4,408.00
Sep 30, 2010 44,260.00
Jun 30, 2010 96,496.00
Mar 31, 2010 148,733.00
Dec 31, 2009 158,552.00
API Access

Tg Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TGTX&period=max&api_key=YOUR_API_KEY